Checkmate Pharmaceuticals
is a Massachusetts-based biopharmaceutical company that develops and commercializes immunotherapies for the treatment of cancer... Read moreCheckmate Pharmaceuticals
is a Massachusetts-based biopharmaceutical company that develops and commercializes immunotherapies for the treatment of cancer... Read more
News
Jun 02, 2022
FirstWord Pharma
Checkmate Pharmaceuticals: Kuros Biosciences: Completion of the Acquisition of Checkmate Pharmaceuticals by Regeneron Pharmaceuticals Triggers a $5 Million Milestone Payment
Jun 02, 2022
Markets Insider
Checkmate Pharmaceuticals: Xoma to get $2.5M from Kuros as Checkmate's acquisition by Regeneron triggers milestone
May 26, 2022
MarketScreener
Checkmate Pharmaceuticals: University of Iowa Holden Comprehensive Cancer Center Presents Preliminary Data from Clinical Trial of Vidutolimod at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
May 17, 2022
MarketScreener
Checkmate Pharmaceuticals: CHECKMATE PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Checkmate Pharmaceuticals, Inc. - CMPI
May 13, 2022
FirstWord Pharma
Checkmate Pharmaceuticals: Checkmate Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Business Update
May 05, 2022
Acrofan
Checkmate Pharmaceuticals: CHECKMATE PHARMACEUTICALS INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Proces
May 03, 2022
PR Newswire
Press Release: Checkmate Pharmaceuticals : SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CMPI, SBOW, SRRA, ATRS
Apr 26, 2022
PR Newswire
Press Release: Checkmate Pharmaceuticals : SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates PSB, FSI, TWTR
Apr 21, 2022
Global Legal Chronicle
Checkmate Pharmaceuticals: Regeneron Pharmaceuticals' Acquisition of Checkmate Pharmaceuticals
Apr 20, 2022
Contract Pharma
Checkmate Pharmaceuticals: Regeneron to Acquire Checkmate Pharmaceuticals in $250M Deal
Checkmate Pharmaceuticals Competitors
1
2
3
4
5
6
7
8
9
10